P
Paulus Kirchhof
Researcher at University of Birmingham
Publications - 659
Citations - 119822
Paulus Kirchhof is an academic researcher from University of Birmingham. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 100, co-authored 558 publications receiving 106459 citations. Previous affiliations of Paulus Kirchhof include United States Department of Veterans Affairs & Georgetown University Medical Center.
Papers
More filters
Journal ArticleDOI
Ablation of atrial fibrillation: for whom and how?
Paulus Kirchhof,Lars Eckardt +1 more
TL;DR: The majority of patients progresses from persistent AF—that is, AF that is managed by rhythm control interventions—to long lasting persistent AF and finally permanent or accepted AF that was managed by rate control and antithrombotic therapy.
Journal ArticleDOI
Extended Electrocardiographic Poincare Analysis (EPA) for Better Identification of Patients with Paroxysmal Atrial Fibrillation
Thomas Duning,Paulus Kirchhof,Heike Wersching,Thomas Hepp,Roland Reinhardt,Hubertus Heuer,Erich Bernd Ringelstein,Stefan Knecht +7 more
TL;DR: Extended Poincare analysis of ECG R-R intervals in patients with a history of PAF is more sensitive to electrocardiographic abnormalities than is conventional 24h- ECG analysis, warranting prospective studies of EPA in Patients with a high likelihood ofPAF, i.e. with stroke of undetermined origin.
Journal ArticleDOI
Predictors of recurrence of atrial fibrillation within the first 3 months after ablation.
Matthias Daniel Zink,Winnie Chua,Stef Zeemering,Luigi Di Biase,Bayes de Luna Antoni,Callans David,Gerhard Hindricks,Karl Georg Haeusler,Hussein R. Al-Khalidi,Jonathan P. Piccini,Lluís Mont,Jens Cosedis Nielsen,Luis Alberto Escobar,Joseph de Bono,Isabelle C. Van Gelder,Tom de Potter,Daniel Scherr,Sakis Themistoclakis,Derick Todd,Paulus Kirchhof,Ulrich Schotten +20 more
TL;DR: Vascular disease and cardioversion during the procedure are strong predictors of recurrent AF, and half of all early AF recurrences within the first 3 months post-ablation occurred within thefirst 14 days post-ABlation.
Journal ArticleDOI
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin
TL;DR: Cardioversion of symptomatic atrial fibrillation is commonly used to restore sinus rhythm, both acutely and as part of a long-term rhythm control strategy, but this approach is associated with a risk of stroke and the efficacy of direct oral anticoagulants compared withDOACs is questionable.
Journal ArticleDOI
Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
Marja Puurunen,Tuomas Kiviniemi,Wail Nammas,Axel Schlitt,Andrea Rubboli,Kai Nyman,Pasi P. Karjalainen,Paulus Kirchhof,Gregory Lip,Juhani Airaksinen +9 more
TL;DR: In this paper, the impact of anaemia on the 12-month clinical outcome of patients with atrial fibrillation (AF) undergoing PCI and therefore requiring intense antithrombotic treatment was analyzed.